Newsroom | 42133 results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year...

シアトル--(BUSINESS WIRE)--（ビジネスワイヤ） -- 医薬品開発者が価格の引き下げおよび市場投入までの期間短縮という、ますます大きな圧力に直面する中、グローバルなバイオ医薬品開発製造受託機関（CDMO）であるAGCバイオロジクスは、ATUMと提携し、Leap-In Transposase®発現プラットフォームを自社の提供内容に統合することで、Cell Line Development Center of Excellenceを拡大しています。この提携により、医薬品開発者は、生産性を高め、臨床試験までのプロセスを大幅に短縮するよう設計された技術を利用でき、市場が求めるスピードと効率性に直接応えることができます。 ATUMの最新のトランスポゼースベースのプラットフォームがAGCバイオロジクスを通じて利用可能になったことで、同CDMOは、迅速な開発を要する複雑な分子から、タイムラインの重要性が比較的低いより単純なプロジェクトまで、多様な顧客ニーズに応える細胞株開発オプションを幅広く提供できるようになっています。この提携により、がん細胞を死滅させ、ウイルス感染と闘い、自己免...

SEATTLE--(BUSINESS WIRE)--Da Arzneimittelentwickler zunehmend unter Druck stehen, Preise zu senken und die Markteinführungszeit zu verkürzen, erweitert das weltweit tätige biopharmazeutische Auftragsentwicklungs- und Produktionsunternehmen AGC Biologics sein „Center of Excellence“ für Zelllinienentwicklung durch eine Partnerschaft mit ATUM, um die Leap-In-Transposase®-Expressionsplattform in das Leistungsportfolio zu integrieren. Diese Partnerschaft bietet Arzneimittelentwicklern eine Technolog...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the consideration payable in connection with the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The table below sets forth the Total Consideration (as defined below) for each series of Notes. Title of Security CUSIP Number(1) Principal Amount Outstanding U.S. Treasury Reference Security Bloomberg Reference Page Reference Yield Fix...

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Ronald Marston has notified the Board of Directors (the “Board”) that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company’s 2025 fourth quarter common and preferred dividends. Ronald Marston’s Retirement from Board of Directors Mr. Marston has served on the Board since 2015 as an independent director and at differ...

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, announced today that it will host a virtual key opinion leader (KOL) event on Monday, December 15, 2025 at 2:00 PM ET featuring Juan C. Camacho, MD (Florida State University), who will join company management to discuss the unmet need and cur...

SAN FRANCISCO--(BUSINESS WIRE)--EvenUp, category leader in AI for personal injury law, today announced unveiling of its Medical Management Solution and AI Communication Agents....

DUBLIN--(BUSINESS WIRE)--The "Wellness Tourism Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The global wellness tourism market is expected to grow from USD 525.377 billion in 2025 to USD 910.436 billion in 2030, at a CAGR of 11.62%. The global wellness tourism market is experiencing robust growth, driven by rising health consciousness and a growing desire for travel experiences that enhance physical, mental, and emotional well-being. This seg...

CHICAGO--(BUSINESS WIRE)--SullivanCotter and Lotis Blue Consulting Identify Competencies Defining the Future-Ready Health System CEO...

LAUSANNE, Switzerland--(BUSINESS WIRE)--Testmate Health Partners with Intermountain Health to Expand Access to Rapid STI Testing...